Application of 21-gene recurrence score in patients with T1-2, N0-1 ER-positive/HER2 negative breast cancer: Survival analysis in relation to clinical risk score

被引：0
|
作者：
Bae, Soong June [1 ]
Ahn, Sung Gwe [1 ]
Park, Soeun [1 ]
Cha, Chi Hwan [1 ]
Kim, Dooreh [1 ]
Lee, Janghee [1 ]
Jeong, Joon [1 ]
机构：
[1] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Seoul, South Korea
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
breast neoplasm; adjuvant treatment; 21-gene recurrence score; chemotherapy;
D O I：
10.1158/1538-7445.SABCS19-P3-08-68
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-08-68
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer
    Vlastos, G
    Rubio, IT
    Mirza, NQ
    Newman, LA
    Aurora, R
    Alderfer, J
    Buzdar, AU
    Singletary, SE
    ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (08) : 581 - 587
  • [22] Prognostic value of the 21-gene recurrence score in ER-positive,HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients
    Jiayi Wu
    Weiqi Gao
    Xiaosong Chen
    Chunxiao Fei
    Lin Lin
    Weiguo Chen
    Ou Huang
    Siji Zhu
    Jianrong He
    Yafen Li
    Li Zhu
    Kunwei Shen
    Frontiers of Medicine, 2021, 15 (04) : 621 - 628
  • [23] Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients
    Jiayi Wu
    Weiqi Gao
    Xiaosong Chen
    Chunxiao Fei
    Lin Lin
    Weiguo Chen
    Ou Huang
    Siji Zhu
    Jianrong He
    Yafen Li
    Li Zhu
    Kunwei Shen
    Frontiers of Medicine, 2021, 15 : 621 - 628
  • [24] Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients
    Wu, Jiayi
    Gao, Weiqi
    Chen, Xiaosong
    Fei, Chunxiao
    Lin, Lin
    Chen, Weiguo
    Huang, Ou
    Zhu, Siji
    He, Jianrong
    Li, Yafen
    Zhu, Li
    Shen, Kunwei
    FRONTIERS OF MEDICINE, 2021, 15 (04) : 621 - 628
  • [25] Survival outcomes according to tumor-infiltrating lymphocytes and 21-gene recurrence score in ER+HER2-breast cancer
    Ahn, S. G.
    Ho, B. Seung
    Minji, L.
    Moon, S.
    Kook, Y.
    Bae, S. J.
    Lee, S. B.
    Jeong, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S338 - S339
  • [26] The Distribution and Outcomes of the 21-Gene Recurrence Score in T1-T2N0 Estrogen Receptor-Positive Breast Cancer With Different Histologic Subtypes
    Wang, Jun
    He, Zhen-Yu
    Dong, Yong
    Sun, Jia-Yuan
    Zhang, Wen-Wen
    Wu, San-Gang
    FRONTIERS IN GENETICS, 2018, 9
  • [27] Oestrogen module of 21-gene recurrence score predicts increased late recurrence for ER+HER2-breast cancer
    Dowsett, M.
    Sestak, I.
    Buus, R.
    Lopez-Knowles, E.
    Cuzick, J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S105 - S106
  • [28] Role of 21-gene recurrence score in patients age ≥70 with T1N0 ER/PR+HER2-breast cancer treated with breast-conserving surgery and endocrine therapy.
    Chevli, Neil Chandrabhan
    Haque, Waqar
    Tran, Kevin Thomas
    Farach, Andrew M.
    Schwartz, Mary R.
    Geyer, Charles E.
    Hatch, Sandra S.
    Butler, E. Brian
    Teh, Bin S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] META-ANALYSIS OF PROSPECTIVE EUROPEAN STUDIES ASSESSING THE IMPACT OF USING THE 21-GENE RECURRENCE SCORE ASSAY ON CLINICAL DECISION MAKING IN WOMEN WITH ER-POSITIVE, HER2-NEGATIVE EARLY STAGE BREAST CANCER
    Albanell, J.
    Holt, S.
    Gligorov, J.
    Eiermann, W.
    Svedman, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 97 - 97
  • [30] Tumor-infiltrating lymphocytes (TILs) and 21-gene recurrence score in 1,883 patients with ER+/HER2-breast cancer
    Ahn, Sung Gwe
    Jang, Ji Soo
    Kook, Yoonwon
    Baek, Seung Ho
    Lee, Sae Byul
    Bae, Soong June
    Jeong, Joon
    CANCER RESEARCH, 2023, 83 (05)
12345